CAV1 and cancer: In the present study, over-expressed lnc-BMP1-1 could increase the expression of Cav-1 and enhance the sensitivity of A549 cells to Doxorubicin, a conclusion that sheds light on the usage of lnc-BMP1-1 in cancer treatment.